Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Masatoshi Hayasaka

Effects of Antacids on Clinical Efficacy of Gefitinib in Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

2017

English

Development of an Auto Monitoring System for the Drug Interaction on Prescription and Injectable Drug Prescription.

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

2001

English

Related publications

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

English

Gefitinib Induces Premature Senescence in Non-Small Cell Lung Cancer Cells With or Without EGFR Gene Mutation

English

Ce4 - Cost-Effectiveness Analysis of First-Line Osimertinib in Patients With Egfr Mutation-Positive Non-Small Cell Lung Cancer

English

Clinical Outcome of Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Harboring Uncommon EGFR Mutation

English

Treatment of EGFR Mutation–positive Non–small Cell Lung Cancer Complicated by Trousseau Syndrome With Gefitinib Followed by Osimertinib: A Case Report

Oncotarget

Oncology

2018

English

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

English

Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer

English

Clinical Analysis of EGFR‐ Positive Non‐small Cell Lung Cancer Patients Treated With First‐line Afatinib: A Nagano Lung Cancer Research Group

English

Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib

Biologics: Targets and Therapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Masatoshi Hayasaka

Effects of Antacids on Clinical Efficacy of Gefitinib in Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer

Development of an Auto Monitoring System for the Drug Interaction on Prescription and Injectable Drug Prescription.

Related publications

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

Gefitinib Induces Premature Senescence in Non-Small Cell Lung Cancer Cells With or Without EGFR Gene Mutation

Ce4 - Cost-Effectiveness Analysis of First-Line Osimertinib in Patients With Egfr Mutation-Positive Non-Small Cell Lung Cancer

Clinical Outcome of Treatment of Metastatic Non-Small Cell Lung Cancer in Patients Harboring Uncommon EGFR Mutation

Treatment of EGFR Mutation&#x2013;positive Non&#x2013;small Cell Lung Cancer Complicated by Trousseau Syndrome With Gefitinib Followed by Osimertinib: A Case Report

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer

Clinical Analysis of EGFR‐ Positive Non‐small Cell Lung Cancer Patients Treated With First‐line Afatinib: A Nagano Lung Cancer Research Group

Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib

Treatment of EGFR Mutation–positive Non–small Cell Lung Cancer Complicated by Trousseau Syndrome With Gefitinib Followed by Osimertinib: A Case Report